News

AVA-101 also showed an improvement on best corrected visual acuity (BCVA) compared with the control group and a positive trend in response rate (stable vision with few rescue

Under the terms of the multi-year agreement, PCT will provide current good manufacturing practice (cGMP) services for the manufacture of clinical supplies of ICT-107, a dendritic cell-based immunotherapy

The Company has licensed an AAV gene therapy and IP from the University of Minnesota to treat patients with Fanconi anemia (FA) disorder and other rare blood diseases.

The Hungarian Nobel-prize winning scientist Albert Szent-Györgyi envisioned cancer cures that go beyond large molecules including genes and proteins, but rather target sub-molecular mechanisms, where the electrons play

Harbin Gloria Pharmaceuticals (Gloria) will design and conduct the trial under the terms of its exclusive license, development, commercialization and supply agreement with Sucampo for Amitiza in China.

The new facility, located near the company’s existing Suzhou site, will help increase production capacity to meet growing demand for Pfizer Consumer Healthcare’s brands in China and the

NTRA-9620 is intended to improve post-resection bowel adaptation as well as patient outcomes, which includes reducing reliance on parenteral nutrition support and increasing enteral nutrition intake. The company

The Phase III trial is planned to be conducted in collaboration with the Gynecologic Oncology Group (GOG) Foundation and will be led by principal investigator from University of

As part of the deal, KODE would secure up to $31m in development and sales milestones, plus royalties on net sales, while Agalimmune will have exclusive rights to